Core Viewpoint - The major shareholder and actual controller of Zhejiang Gongdong Medical Instrument Co., Ltd., Shi Huiyong, plans to reduce his shareholding through block trading and centralized bidding methods, indicating a personal funding need [1][3]. Group 1: Shareholder Information - Shi Huiyong holds 110,836,040 shares, representing 50.27% of the company, while Taizhou Jinch Investment Management Partnership holds 14,258,009 shares, accounting for 6.47% [2]. - The total shareholding of Shi Huiyong and his family member, Shi Yibei, along with Jinch Investment, amounts to 141,558,049 shares, which is 64.21% of the total shares [2]. Group 2: Reduction Plan Details - Shi Huiyong intends to reduce his holdings by up to 4,409,858 shares, not exceeding 2% of the total shares, through block trading from September 26, 2025, to December 24, 2025 [3]. - Taizhou Jinch Investment plans to reduce its holdings by up to 2,204,929 shares, not exceeding 1% of the total shares, through centralized bidding during the same period [3]. - The reduction is motivated by personal funding needs for both Shi Huiyong and Taizhou Jinch Investment [3]. Group 3: Compliance and Commitments - The reduction plan complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [6]. - The company will adhere to disclosure obligations and will not alter commitments made regarding shareholding during the lock-up period [4][5].
拱东医疗: 拱东医疗:股东减持股份计划公告